These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 21711115

  • 1. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.
    Shirmardi SP, Gandomkar M, Maragheh MG, Shamsaei M.
    Cancer Biother Radiopharm; 2011 Jun; 26(3):309-16. PubMed ID: 21711115
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [Abstract] [Full Text] [Related]

  • 3. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS.
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [Abstract] [Full Text] [Related]

  • 4. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
    Dijkgraaf I, Franssen GM, McBride WJ, D'Souza CA, Laverman P, Smith CJ, Goldenberg DM, Oyen WJ, Boerman OC.
    J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
    [Abstract] [Full Text] [Related]

  • 5. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
    Lim JC, Cho EH, Kim JJ, Choi SM, Lee SY, Nam SS, Park UJ, Park SH.
    Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
    [Abstract] [Full Text] [Related]

  • 6. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D, Xu YP, Yang RH, Wang L, Chen F, Luo S, Yang M, Yan Y.
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [Abstract] [Full Text] [Related]

  • 7. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
    Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA.
    J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector.
    Abd-Elgaliel WR, Gallazzi F, Garrison JC, Rold TL, Sieckman GL, Figueroa SD, Hoffman TJ, Lever SZ.
    Bioconjug Chem; 2008 Oct; 19(10):2040-8. PubMed ID: 18808168
    [Abstract] [Full Text] [Related]

  • 9. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
    Koumarianou E, Mikołajczak R, Pawlak D, Zikos X, Bouziotis P, Garnuszek P, Karczmarczyk U, Maurin M, Archimandritis SC.
    Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
    [Abstract] [Full Text] [Related]

  • 10. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
    Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.
    Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.
    Yang YS, Zhang X, Xiong Z, Chen X.
    Nucl Med Biol; 2006 Apr; 33(3):371-80. PubMed ID: 16631086
    [Abstract] [Full Text] [Related]

  • 12. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.
    J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
    [Abstract] [Full Text] [Related]

  • 13. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA, Kaloudi A, Lymperis E, Giarika A, Kulkarni HR, Klette I, Singh A, Krenning EP, de Jong M, Maina T, Baum RP.
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [Abstract] [Full Text] [Related]

  • 14. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR.
    J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
    [Abstract] [Full Text] [Related]

  • 15. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [Abstract] [Full Text] [Related]

  • 16. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC, Rold TL, Sieckman GL, Figueroa SD, Volkert WA, Jurisson SS, Hoffman TJ.
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Ait-Mohand S, Fournier P, Dumulon-Perreault V, Kiefer GE, Jurek P, Ferreira CL, Bénard F, Guérin B.
    Bioconjug Chem; 2011 Aug 17; 22(8):1729-35. PubMed ID: 21761921
    [Abstract] [Full Text] [Related]

  • 18. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
    Maina T, Bergsma H, Kulkarni HR, Mueller D, Charalambidis D, Krenning EP, Nock BA, de Jong M, Baum RP.
    Eur J Nucl Med Mol Imaging; 2016 May 17; 43(5):964-973. PubMed ID: 26631238
    [Abstract] [Full Text] [Related]

  • 19. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.
    Schweinsberg C, Maes V, Brans L, Bläuenstein P, Tourwé DA, Schubiger PA, Schibli R, García Garayoa E.
    Bioconjug Chem; 2008 Dec 17; 19(12):2432-9. PubMed ID: 19053304
    [Abstract] [Full Text] [Related]

  • 20. [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.
    Prasanphanich AF, Nanda PK, Rold TL, Ma L, Lewis MR, Garrison JC, Hoffman TJ, Sieckman GL, Figueroa SD, Smith CJ.
    Proc Natl Acad Sci U S A; 2007 Jul 24; 104(30):12462-7. PubMed ID: 17626788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.